Author:
White Roseann,Lam Peter,Lu Nelson,Su Xiaolu,Bergemann Tracy,Johnson Terri,Stephens Dan,Farb Andrew,Jaff Michael,Lansky Alexandra,Kirtane Ajay,Rymer Jennifer,Krucoff Mitchell
Reference26 articles.
1. Food and Drug Administration. Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency: Guidance for Industry, Investigators and Institutional Review Boards; March 2020/August 30 2021https://www.fda.gov/media/136238/download. [accessed 15 August 2023].
2. Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: a think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet);Zeitler;Am Heart J,2016
3. One-year follow-up of vascular intervention trials disrupted by the COVID-19 pandemic: a use-case landscape;Rymer;CRM,2022
4. World Health Organization. Pandemic Influenza Risk Management, WHO Interim Guidance, Figure 1. The Continuum of Pandemic Phaseshttps://www.who.int/publications/i/item/pandemic-influenza-risk-management. [accessed 16 January 2024].